You need to look at more tradition valuation methods Go old school; the simple PE Ratio method.
Lets stipulate CYDY receives Flu approval in 6 weeks. 1,000,000 doses can be made in two weeks. My own research
1,000,000 doses will not be enough, now another is ordered back to back. The US firm close to Seattle is called to make more doses. I DO NOT know their capacity but will find that answer.
2,000,000 doses is 2 billion $$ in sales and roughly 2$ per share.
If all the above occurred I believe the market would bring our stock price to a 50 Ratio. Why, because we are cutting edge with no Big Pharma drugs that can match ours. WE have a shot at reaching a 100 PE Ratio
50 PE = 100$
You need to think about what I am laying out. This can happen. I invite all to shoot holes in my analysis.
Remember where you first read this.
Big Picture